Paul Bolno, Wave Life Sciences CEO

First clin­i­cal test of RNA edit­ing re­stores miss­ing pro­tein in ge­net­ic dis­ease, Wave says

An ex­per­i­men­tal ther­a­py de­signed to change a sin­gle let­ter of short-lived mR­NA mol­e­cules has cor­rect­ed a ge­net­ic mu­ta­tion that pre­vents peo­ple from mak­ing a vi­tal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.